Elicio Therapeutics

Last updated: October 11, 2024

CEO Darrell Irvine
CEO Darrell Irvine
USA | Funding: $253.8M (+)

Website: https://elicio.com

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.